Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
60.08B | 63.94B | 51.50B | 53.40B | 47.44B | 40.14B | Gross Profit |
6.63B | 9.30B | 1.56B | 5.76B | 5.87B | 3.65B | EBIT |
973.00M | 3.44B | -3.54B | 304.00M | 649.00M | -1.29B | EBITDA |
-1.76B | 3.73B | -5.48B | 4.51B | 4.59B | 2.98B | Net Income Common Stockholders |
-7.88B | -769.00M | -11.82B | 557.00M | 904.00M | 61.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.66B | 9.20B | 7.42B | 7.71B | 7.51B | 7.57B | Total Assets |
59.41B | 60.17B | 60.45B | 63.73B | 57.93B | 53.38B | Total Debt |
15.21B | 15.58B | 14.79B | 11.03B | 7.22B | 4.34B | Net Debt |
7.55B | 6.38B | 7.37B | 3.32B | -294.00M | -3.23B | Total Liabilities |
32.72B | 33.58B | 31.10B | 25.70B | 20.75B | 17.06B | Stockholders Equity |
26.69B | 26.59B | 29.35B | 38.03B | 37.18B | 36.32B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.44B | -3.95B | -2.32B | -2.07B | -2.19B | Operating Cash Flow |
0.00 | 654.00M | 678.00M | 1.69B | 3.17B | 3.01B | Investing Cash Flow |
0.00 | 1.00B | -4.32B | -4.95B | -4.82B | -4.36B | Financing Cash Flow |
0.00 | -284.00M | 2.88B | 2.78B | 1.15B | 250.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥8.21B | 2.78 | 3.04% | 2.17% | 66.19% | ||
76 Outperform | ¥9.60B | 4.45 | 5.57% | 1.49% | 93.90% | ||
71 Outperform | ¥8.77B | 7.04 | 3.45% | 8.63% | 9.65% | ||
70 Outperform | ¥8.56B | 6.00 | 7.23% | 0.69% | 7.21% | ||
67 Neutral | ¥10.92B | 173.22 | 5.94% | 2.22% | -90.98% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
51 Neutral | ¥8.70B | ― | 3.25% | 24.16% | 93.48% |